Skip to main content
SpringerLink
Log in
Book cover

Kernicterus pp 189–201Cite as

Progressive Familial Intrahepatic Cholestasis

  • Chapter
  • First Online:

  • 799 Accesses

Part of the book series: Contemporary Clinical Neuroscience ((CCNE))

Abstract

Progressive familial intrahepatic cholestasis (PFIC) is a progressive disorder that affects children. It is initially characterized by intrahepatic cholestasis which worsens over time. It may present with jaundice in the first weeks of life, or may appear after several months. Byler’s disease, another term for one type of PFIC, was coined after an immigrant who brought the disorder to the USA. PFIC is a rare inherited disorder in which at least three subtypes have been identified, and called PFIC-1, PFIC-2, and PFIC-3. These three subtypes carry descriptive names which partially describe them: PFIC-1 is called familial intrahepatic cholestasis, PFIC-2 may be called bile salt export pump deficiency, and PFIC-3 is multidrug resistant-associated protein deficiency. A mild not as severe form of PFIC is called benign recurrent intrahepatic cholestasis.

This chapter is dedicated to Isabella (Bella) Hubner, and her parents Doug and Michelle Hubner.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ahboucha, S., and Butterworth, R. (2007) The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis. 22:291–308

    Article  PubMed  CAS  Google Scholar 

  • Anderson, G. (2004) Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63:S24–S29

    Article  Google Scholar 

  • Balistreri, W. (1997) Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J. Pediatr. Gastro. Nutrit. 24:573–589

    Article  CAS  Google Scholar 

  • Belanger, M., and Butterworth, R. (2005) Acute liver failure: A critical appraisal of available animal models. Met. Brain Dis. 20:409–424

    Article  Google Scholar 

  • Cauli, O., et al. (2005) Altered modulation of motor activity by group 1 metabotropic glutamate receptors in the nucleus accumbens in hyperammonemic rats. Metab. Brain Dis. 20:347–358

    Article  PubMed  CAS  Google Scholar 

  • Chalmers, T. (1960) Pathogenesis and treatment of hepatic failure. N. Engl. J. Med. 263:23–30

    Article  PubMed  CAS  Google Scholar 

  • Chenard-Neu, M., et al. (1996) Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure. Hepatology 23:1119–1127

    PubMed  CAS  Google Scholar 

  • de Lacerda, G. (2008) Treating seizures in renal and hepatic failure. J. Epil. Clin. Neurophys. 14:1–8

    Google Scholar 

  • de Vree, J., et al. (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. 98:282–287

    Article  Google Scholar 

  • Eleftheriadis, N., et al. (2003) Status epilepticus as a manifestation of hepatic encephalopathy. Acya Neurol. Scand. 107:142–144

    Article  CAS  Google Scholar 

  • Gimson, A. (1996) Fulminant and late onset hepatic failure Brit. J. Anaesth. 77:90–98

    Article  CAS  Google Scholar 

  • Hoofnagle, J., et al. (1995) Fulminant hepatic failure: summary of a workshop. Hepatology 21:240–252

    PubMed  CAS  Google Scholar 

  • Jansen, P., and Muller, M. (2000) The molecular genetics of familial intrahepatic cholestasis. GUT 47:1–5

    Article  PubMed  CAS  Google Scholar 

  • Karrer, F., et al. (1984) A reproducible large animal model of acute hepatic failure. Curr. Surg. 41:464–467

    PubMed  CAS  Google Scholar 

  • Khalil, A. (2000) Byler disease progressive familial intrahepatic cholestasis Hepatology 32:1337–1341

    Article  Google Scholar 

  • Ko, J., et al. (2007) Neonatal intrahepatic cholestasis caused by citrin deficiency in Korean infants. J. Korean Med. Sci. 22:952–956

    Article  PubMed  CAS  Google Scholar 

  • Krahenbuhl, S., et al. (1995) Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology 22:607–612

    PubMed  CAS  Google Scholar 

  • Llansola, M., et al. (2007) NMDA receptors in hyperammonemia and hepatic encephalopathy. Metab. Brain Dis. 22:321–336

    Article  PubMed  CAS  Google Scholar 

  • Mohanty, A., and Schiff, E. (2009) The dilemma of idiopathic fulminant hepatic failure. Gastroent. Hepatol. 5:48–52

    Google Scholar 

  • Rao, K., and Norenberg, M. (2007) Aquaporin-4 in hepatic encephalopathy. Metab. Brain Dis. 22:265–276

    Article  CAS  Google Scholar 

  • Roger, V., et al. (1996) A good model of acute hepatic failure: 95% hepatectomy. Chirurgie 121:470–473

    PubMed  CAS  Google Scholar 

  • Romero-Gomez, M. (2005) Role of phosphate activated glutaminase in the pathogenesis of hepatic encephalopathy. Metab. Brain Dis. 20:319–326

    Article  PubMed  CAS  Google Scholar 

  • Saheki, T., et al. (2004) Adult onset type 2 citrullinemia and idiopathic neonatal hepatitus caused by citrin deficiency. Mol. Genet. Metab. 81:s20–s26

    Article  PubMed  CAS  Google Scholar 

  • Sass, D., and Shakil, A. (2005) Fulminant hepatic failure. Liver Transpl. 11:594–605

    Article  PubMed  Google Scholar 

  • Schenker, S., et al. (1967) Studies on the intracerebral toxicity of ammonia. J. Clin. Med. 46:838–848

    CAS  Google Scholar 

  • Shet, R. (2004) Metabolic concerns associated with antiepileptic medications. Neurology 63:24–29

    Article  Google Scholar 

  • Shigematsu, Y., et al. (2002) Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J. Chrom B Analyt. Tech. Biomed. Life Sci. 776:39–48

    Article  CAS  Google Scholar 

  • Smetana, H., Edlow, J., and Glunz, P. (1965) Neonatal jaundice. Arch. Path. 80:553–574

    PubMed  CAS  Google Scholar 

  • Soylu, A., et al. (2008) Intrahepatic cholestasis in subclinical and overt hyperthyroidism: two case reports. J. Med. Case Rep. 2:116–123

    Article  PubMed  Google Scholar 

  • van Nievwkerk, C., et al. (1996) Progressive familial intrahepatic cholestasis Gastroent 111:165–171

    Article  Google Scholar 

  • Wang, X., and Anderson, R. (1994) Hepatocyte transplantation : a potential treatment for acute liver failure. Scand. J. Gastroent. 30:193–200

    Article  Google Scholar 

  • WHO Severe and complicated malaria: A report of the WHO malaria action programme. Trans. R. Soc. Med. Hyg. 80:1–50

    Google Scholar 

  • Wright, G., et al. (2007) Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab. Brain Dis. 22:375–388

    Article  PubMed  CAS  Google Scholar 

  • Zieve, L. (1966) Pathogenesis of hepatic coma. Arch. Int. Med. 118:211–220

    Article  CAS  Google Scholar 

  • Zimmerman, H. (1986) Effects of alcohol on other hepatotoxins. Alcohol. Clin. Exp. Res. 10:3–15

    Article  PubMed  CAS  Google Scholar 

  • Rose, C., and Felipo, V. (2005) Limited capacity for ammonia removal by brain in chronic liver failure: potential role of nitric oxide. Metab. Brain Dis. 20:275–284

    Article  PubMed  CAS  Google Scholar 

  • Tobias, J. (2002) Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients. South. Med. J. online Nov 1, 2002, a09723387

    Google Scholar 

  • Bhatia, V., Batra, Y., and Acharya, S. (2004) Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controled clinical trial. J. Hepatol. 41:89–96

    Article  PubMed  CAS  Google Scholar 

  • Javitt, J. (1966) Cholestasis in rats induced by taurolithocholate. Nature 210:599–604

    Article  Google Scholar 

  • Kelly, J., et al. (1992) An improved model of acetaminophen induced fulminant hepatic failure in dogs. Hepatology 15:329–335

    Article  PubMed  CAS  Google Scholar 

  • Calmus, Y., et al. (1990) Hepatic expression of class I and class II major histocompatability complex molecules in primary biliary. Hepatology 11:12–15

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Biology & Anatomy, Rosalind Franklin University of Medicine & Science, Chicago Medical School, 3333 Green Bay Road, North Chicago, IL, 60064, USA

    David W. McCandless

Authors
  1. David W. McCandless
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David W. McCandless .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

McCandless, D.W. (2011). Progressive Familial Intrahepatic Cholestasis. In: Kernicterus. Contemporary Clinical Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4419-6555-4_18

Download citation

Publish with us

Policies and ethics

Search

Navigation